2H-1-Benzopyran-2-one, 4,6-dihydroxy-3-(3-oxo-1-phenylbutyl)-
| Title | Journal |
|---|---|
| Warfarin is an effective modifier of multiple UDP-glucuronosyltransferase enzymes: evaluation of its potential to alter the pharmacokinetics of zidovudine. | Journal of pharmaceutical sciences 20150101 |
| The population pharmacokinetics of R- and S-warfarin: effect of genetic and clinical factors. | British journal of clinical pharmacology 20120101 |
| Analysis of R- and S-hydroxywarfarin glucuronidation catalyzed by human liver microsomes and recombinant UDP-glucuronosyltransferases. | The Journal of pharmacology and experimental therapeutics 20120101 |
| Hydroxywarfarin metabolites potently inhibit CYP2C9 metabolism of S-warfarin. | Chemical research in toxicology 20100517 |
| Assessing cytochrome P450 and UDP-glucuronosyltransferase contributions to warfarin metabolism in humans. | Chemical research in toxicology 20090701 |
| Identification of hydroxywarfarin binding site in human UDP glucuronosyltransferase 1a10: phenylalanine90 is crucial for the glucuronidation of 6- and 7-hydroxywarfarin but not 8-hydroxywarfarin. | Drug metabolism and disposition: the biological fate of chemicals 20081101 |
| Synthesis and structure-activity relationships of novel warfarin derivatives. | Bioorganic & medicinal chemistry 20070315 |
| Determination of warfarin enantiomers and hydroxylated metabolites in human blood plasma by liquid chromatography with achiral and chiral separation. | Journal of chromatography. B, Analytical technologies in the biomedical and life sciences 20050425 |